These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
655 related items for PubMed ID: 18374637
1. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA. Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637 [Abstract] [Full Text] [Related]
3. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T, Voigt E, Gretzer B, Brasch F, May B. Hepatogastroenterology; 1999 Aug; 46(26):920-3. PubMed ID: 10370639 [Abstract] [Full Text] [Related]
4. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558 [Abstract] [Full Text] [Related]
5. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H. J Gastroenterol; 2003 Mar; 38(3):229-37. PubMed ID: 12673445 [Abstract] [Full Text] [Related]
6. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. Konno S, Iizuka M, Yukawa M, Sasaki K, Sato A, Horie Y, Nanjo H, Fukushima T, Watanabe S. J Gastroenterol; 2004 Oct; 39(10):931-9. PubMed ID: 15549445 [Abstract] [Full Text] [Related]
12. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis. Yokoyama K, Mitomi H, Kobayashi K, Katsumata T, Saigenji K, Okayasu I. Hepatogastroenterology; 2001 Feb; 48(38):401-7. PubMed ID: 11379318 [Abstract] [Full Text] [Related]
13. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, Kohno S. Hepatogastroenterology; 2002 Feb; 49(45):678-82. PubMed ID: 12063968 [Abstract] [Full Text] [Related]
14. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Nielsen OH, Brynskov J, Bendtzen K. Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600 [Abstract] [Full Text] [Related]
15. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Banks C, Bateman A, Payne R, Johnson P, Sheron N. J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223 [Abstract] [Full Text] [Related]
18. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells. Lügering N, Stoll R, Holzgreve A, Winde G, Sorg C, Domschke W. Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869 [Abstract] [Full Text] [Related]